# Nemis Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nemis-technologies

- Industry: Biotechnology
- Headquarters: Zurich, Switzerland
- Website: www.nemistech.com
- Total disclosed funding: $8.4M
- Latest round: Series A (Feb 3, 2022)
- Investors on record: 1

## About

Based in Switzerland, NEMIS Technologies AG specializes in food safety testing solutions, providing rapid diagnostic technologies that ensure the safety of food production processes across the global food industry.Founded in 2018 and headquartered in Zurich, Switzerland, NEMIS Technologies AG is focused on developing innovative testing solutions for the food industry. The company has engaged in three deals, with the most recent being a Series A funding round in February 2022 led by Clave Capital, raising a total of CHF 7.75 million. Mario Hupfeld serves as the founder and CEO of the company.NEMIS Technologies specializes in innovative food safety testing solutions tailored for food producers, offering a suite of proprietary diagnostic technologies designed to ensure safe food production. Their core products include the N-Light™ series, which facilitates rapid and accurate on-site detection of pathogens such as Listeria spp., Salmonella, E. coli, and others. These solutions empower quality control teams to identify contamination risks in real-time, significantly enhancing food safety measures across various production settings. NEMIS Technologies serves a diverse clientele that spans the global food industry, including manufacturers, distributors, and retailers in North America, Europe, and Asia. Their systems are deployed in food processing plants, laboratories, and testing facilities, ultimately benefiting consumers by reducing the incidence of foodborne illnesses.NEMIS Technologies operates on a B2B model, engaging directly with food producers and related stakeholders. Their revenue model is primarily driven by the sale of diagnostic products and associated services, including subscriptions to their NEMIS Academy for ongoing training and education in food safety. Clients typically purchase diagnostic kits like the N-Light™ products, which are designed for rapid pathogen detection, thereby facilitating quicker responses to potential contamination issues. Additionally, the company fosters partnerships with laboratories for enhanced data integration and monitoring solutions. The transaction structure involves bulk purchasing agreements, where clients secure significant quantities of testing kits and associated services to meet their operational needs effectively.In February 2022, Nemis Technologies AG raised CHF 7.75 million in Series A funding led by Clave Capital, which will be utilized to scale-up production and pursue global expansion strategies. The company is actively designing new products to enhance its testing capabilities and aims to enter new markets within Europe and Asia by the end of 2023. Expansion plans include increasing their presence in regions with high food safety concerns, thereby broadening their impact in the global food industry.

## Funding rounds

- Series A, Feb 3, 2022, $8.4M — Clave Capital

## Investors

- Clave Capital — Series A